Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-013666

Options or other derivatives

  • Chief Financial Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Quinn William P. Chief Financial Officer 2023-02-27 Grant or award · Stock Option (Right to Buy) +250,000 250,000 D
Loading xslF345X03/doc4.xml…